From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool
Non-enhancement
Enhancement
p value
Major adverse effect
No
14 (87.5%)
3 (20%)
*p ≤0.001
Yes
2 (12.5%)
12 (80%)